🇺🇸 FDA
Patent

US 12280149

Manufacturing of bupivacaine multivesicular liposomes

granted A61KA61K31/445A61K9/0019

Quick answer

US patent 12280149 (Manufacturing of bupivacaine multivesicular liposomes) held by Pacira Pharmaceuticals, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/445, A61K9/0019, A61K9/127, A61K9/1277